Glenmark Pharma plans capital expense of $300 mn in three years
Pharma major Glenmark Pharmaceuticals has chalked out a $300 million capital expenditure plan for the next three years to fund […]
GLENN-SALDANHA
Pharma major Glenmark Pharmaceuticals has chalked out a $300 million capital expenditure plan for the next three years to fund […]
